相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice
Javier P. Gisbert et al.
JOURNAL OF CROHNS & COLITIS (2020)
P378 Mucosal healing is achieved in most of the inflammatory bowel disease patients in clinical remission with vedolizumab: a real-life single-centre experience
M I Calvo Moya et al.
Journal of Crohns & Colitis (2020)
Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
Silvio Danese et al.
GASTROENTEROLOGY (2019)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Anna-Maria Schneider et al.
BMC GASTROENTEROLOGY (2018)
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Maria Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder et al.
JOURNAL OF CROHNS & COLITIS (2017)
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
A. Stallmach et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
Aurelien Amiot et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Efficacy and safety of vedolizumab in the treatment of ulcerative colitis
Eugeni Domenech et al.
Gastroenterologia y Hepatologia (2016)
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Namita Singh et al.
INFLAMMATORY BOWEL DISEASES (2016)
Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
Maire A. Conrad et al.
INFLAMMATORY BOWEL DISEASES (2016)
Vedolizumab in the treatment of Crohn's disease
Javier P. Gisbert et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2015)
Review article: anti-adhesion therapies for inflammatory bowel disease
T. Lobaton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
α4β7 integrin: beyond T cell trafficking
Sarah L. Kempster et al.
GUT (2014)
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
Arie Levine et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
Asit Parikh et al.
INFLAMMATORY BOWEL DISEASES (2013)
In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes
Timothy Wyant et al.
MABS (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Long-term durability of response to adalimumab in Crohn's disease
M. Chaparro et al.
INFLAMMATORY BOWEL DISEASES (2012)
Pediatric Modification of the Montreal Classification for Inflammatory Bowel Disease: The Paris Classification
Arie Levine et al.
INFLAMMATORY BOWEL DISEASES (2011)
Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose Escalation in Patients Losing Response
Maria Chaparro et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Saskia Thomas et al.
INFLAMMOPHARMACOLOGY (2011)
New pathophysiological insights and modern treatment of IBD
Matthias A. Engel et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)